LARGE PAPILLARY UROTHELIAL NEOPLASM OF LOW MALIGNANT POTENTIAL: A CASE REPORT
https://doi.org/10.17650/1726-9776-2018-14-3-139-142
Abstract
Last World Health Organization 2016/ISUP (International Society of Urologic Pathologists) papillary urinary tumor classification include papillary urothelial neoplasm of low malignant potential (PUNLMP). This type of tumor is characterized by minimal atypia as well as low recurrence and progression rates. The article describes a clinical case of large PUNLMP treatment.
About the Authors
A. A. Tomilov
S.P. Botkin City Clinical Hospital, Moscow Healthcare Department
Russian Federation
5 2nd Botkinskiy Proezd, Moscow 125284.
Competing Interests: No conflict of interest.
Russian Federation
5 2nd Botkinskiy Proezd, Moscow 125284.
Competing Interests: No conflict of interest.
I. V. Seregin
S.P. Botkin City Clinical Hospital, Moscow Healthcare Department; Department of Urology and Surgical Andrology, Russian Medical Academy of Postgraduate Education, Ministry of Health of Russia
Russian Federation
5 2nd Botkinskiy Proezd, Moscow 125284; Build. 1, 2/1 Barrikadnaya St., Moscow 125993.
Competing Interests: No conflict of interest.
Russian Federation
5 2nd Botkinskiy Proezd, Moscow 125284; Build. 1, 2/1 Barrikadnaya St., Moscow 125993.
Competing Interests: No conflict of interest.
E. I. Veliev
S.P. Botkin City Clinical Hospital, Moscow Healthcare Department; Department of Urology and Surgical Andrology, Russian Medical Academy of Postgraduate Education, Ministry of Health of Russia
Russian Federation
5 2nd Botkinskiy Proezd, Moscow 125284; Build. 1, 2/1 Barrikadnaya St., Moscow 125993.
Competing Interests: No conflict of interest.
Russian Federation
5 2nd Botkinskiy Proezd, Moscow 125284; Build. 1, 2/1 Barrikadnaya St., Moscow 125993.
Competing Interests: No conflict of interest.
O. V. Paklina
S.P. Botkin City Clinical Hospital, Moscow Healthcare Department
Russian Federation
5 2nd Botkinskiy Proezd, Moscow 125284.
Competing Interests: No conflict of interest.
Russian Federation
5 2nd Botkinskiy Proezd, Moscow 125284.
Competing Interests: No conflict of interest.
G. R. Setdikova
S.P. Botkin City Clinical Hospital, Moscow Healthcare Department
Russian Federation
5 2nd Botkinskiy Proezd, Moscow 125284.
Competing Interests: No conflict of interest.
Russian Federation
5 2nd Botkinskiy Proezd, Moscow 125284.
Competing Interests: No conflict of interest.
References
1. Jones T.D., Cheng L. Papillary urothelial neoplasm of low malignant potential: evolving terminology and concepts. J Urol 2006;175(6):1995–2003. DOI: 10.1016/S0022-5347(06)00267-9. PMID: 16697785.
2. Moch H., Humphrey P.A., Ulbright T.M., Reuter V. WHO classification of tumours of the urinary system and male genital organs. International Agency for Research on Cancer, Lyon, France, 2016.
3. Cheng L., Neumann R.M., Bostwick D.G. Papillary urothelial neoplasms of low malignant potential. Clinical and biological implications. Cancer 1999;86:2102.
4. Fujii Y., Kawakami S., Koga F. et al. Long-term outcome of bladder papillary urothelial neoplasms of low malignant potential. BJU Int 2003;92(6):559–62. PMID: 14511033.
5. Vedder M.M., Márquez M., de Bekker-Grob E.W. et al. Risk prediction scores for recurrence and progression of non-muscle invasive bladder cancer: an international validation in primary tumours. PLoS One 2014;9(6):e96849. DOI: 10.1371/journal.pone.0096849. PMID: 24905984.
6. Babjuk M., Burger M., Compérat E. et al. EAU Non-muscle-invasive Bladder Cancer Guidelines, 2016. Available at: http://uroweb.org/guideline/non-muscle-invasive-bladder-cancer/.
7. Sylvester R.J., van der Meijden A.P., Oosterlinck W. et al. Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials. Eur Urol 2006;49(3):466–5. DOI: 10.1016/j.eururo.2005.12.031. PMID: 16442208.
8. Zhang X.K., Wang Y.Y., Chen J.W., Qin T. Bladder papillary urothelial neoplasm of low malignant potential in Chinese: a clinical and pathological analysis. Int J Clin Exp Pathol 2015;8(5):5549–55. PMID: 26191263.
9. Maxwell J.P., Wang C., Wiebe N. et al. Long-term outcome of primary Papillary Urothelial Neoplasm of Low Malignant Potential (PUNLMP) including PUNLMP with inverted growth. Diagn Pathol 2015;10:3. DOI: 10.1186/s13000-015-0234-z. PMID: 25886613.
10. Lee T.K., Chaux A., Karram S. et al. Papillary urothelial neoplasm of low malignant potential of the urinary bladder: clinicopathologic and outcome analysis from a single academic center. Human Pathol 2011;42(11):1799–803. DOI: 10.1016/j.humpath.2011.03.006. PMID: 21777949.
11. Pan C.C., Chang Y.H., Chen K.K. et al. Prognostic significance of the 2004 WHO/ISUP classification for prediction of recurrence, progression, and cancer-specific mortality of non-muscle-invasive urothelial tumors of the urinary bladder: a clinicopathologic study of 1,515 cases. Am J Clin Pathol 2010;133(5):788–95. DOI: 10.1309/AJCP12MRVVHTCKEJ. PMID: 20395527.
Review
For citations:
Tomilov A.A., Seregin I.V., Veliev E.I., Paklina O.V., Setdikova G.R. LARGE PAPILLARY UROTHELIAL NEOPLASM OF LOW MALIGNANT POTENTIAL: A CASE REPORT. Cancer Urology. 2018;14(3):139-142. (In Russ.) https://doi.org/10.17650/1726-9776-2018-14-3-139-142
Views:
4511
Email this article 